Neurocrine Biosciences Leadership Change
Neurocrine Biosciences appointed Eiry W. Roberts, M.D., as Chief Medical Officer, succeeding Sanjay Keswani, M.D., effective September 28, 2026. Dr. Roberts will receive an annual base salary of $825,000, a 60% target bonus, and equity grants totaling approximately $1.25 million in target value. Dr. Keswani's departure was described as a mutual agreement, and he will receive severance benefits under the company's existing executive plan.
- Counterparty
- Eiry W. Roberts, M.D.